Repository logo
 
Publication

The ABCD assessment tool: relationship with the clinical outcomes of patients with COPD

2018Other Open access
Simple item page
dc.contributor.authorMarques, Alda
dc.contributor.authorMiranda, Sara
dc.contributor.authorPaixão, Cátia
dc.contributor.authorValente, Carla
dc.contributor.authorAndrade, Lília
dc.contributor.authorCruz, Joana
dc.contributor.authorJácome, Cristina
dc.contributor.authorMachado, Ana
dc.date.accessioned2019-10-04T13:32:54Z
dc.date.available2019-10-04T13:32:54Z
dc.date.issued2018
dc.description.abstractThe ABCD assessment tool for patients with chronic obstructive pulmonary disease (COPD) has recently been revised. Few studies have evaluated patients’ clinical characteristics based on this classification, although it may be important to adjust interventions to patients’ specific needs. This study explored the distribution of the most used clinical outcomes in patients with COPD across ABCD groups. A cross sectional study was conducted. Patients with COPD were recruited from routine pulmonology appointments and primary care centres in Portugal. Assessments included a spirometric test, quadriceps muscle strength (QMS) with handheld dynamometer, inspiratory muscle strength with the maximal inspiratory pressure (MIP), functional performance with the 1-minute sit-to-stand test (1-min STS) and health-related quality of life with the Saint George Respiratory Questionnaire (SGRQ). Patients were classified into ABCD groups based on the modified British Medical Research Council dyspnoea questionnaire and history of exacerbations in the previous year. One-way ANOVA and Bonferroni corrections for multiple comparisons were used to explore differences between groups. Three hundred and twenty-nine patients with COPD (253 (77%) male, 67±10 years old, forced expiratory volume in one second 60±25 % of predicted, forced vital capacity 81±23 % of predicted, body mass index 28±16 kg/m2; 73 (22%) GOLD I, 133 (40%) GOLD II, 90 (27%) GOLD III, 33 (10%) GOLD IV) participated. Group A was the most prevalent (131; 40%), followed by groups B (95; 29%), D (70; 21%) and C (33; 10%). Patients from groups B and D, which are the most symptomatic, presented the worst results for all outcomes (Figure 1). Patients from ABCD groups present different clinical characteristics. The ABCD classification appears to be important to discriminate patients with worst outcomes, hence it may be useful to personalise treatments according to patients’ needs and clinical characteristics.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.citationMarques, Alda & Miranda, Sara & Paixão, Cátia & Valente, Carla & Andrade, Lília & Cruz, Joana & Jácome, Cristina & Machado, Ana. (2018). The ABCD Assessment Tool – Relationship with clinical outcomes of patients with COPD.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.8/4166
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relationPOCI-01-0145- FEDER-007628pt_PT
dc.relationPTDC/DTP-PIC/2284/2014 - FCTpt_PT
dc.relationInstitute for Biomedicine - Aveiro
dc.subjectGOLD criteriapt_PT
dc.subjectCOPDpt_PT
dc.subjectPerformancept_PT
dc.subjectQuality of life measurementpt_PT
dc.titleThe ABCD assessment tool: relationship with the clinical outcomes of patients with COPDpt_PT
dc.typeother
dspace.entity.typePublication
oaire.awardTitleInstitute for Biomedicine - Aveiro
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIM%2F04501%2F2013/PT
oaire.citation.conferencePlaceCentro de Congressos EPIC Sana, Praia da Falésia (Portugal)pt_PT
oaire.citation.titleXXXIV Congresso da Sociedade Portuguesa de Pneumologia, X Congresso Luso-Brasileiro de Pneumologiapt_PT
oaire.fundingStream6817 - DCRRNI ID
person.familyNameMarques
person.familyNameCruz
person.givenNameAlda
person.givenNameJoana
person.identifier.ciencia-idDE15-EFBA-4856
person.identifier.ciencia-idE213-7D20-5C3C
person.identifier.orcid0000-0003-4980-6200
person.identifier.orcid0000-0002-4911-4469
person.identifier.ridK-7030-2013
person.identifier.scopus-author-id36715922000
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typeotherpt_PT
relation.isAuthorOfPublication2b4618ae-9c47-4033-94ea-24c9793d73e7
relation.isAuthorOfPublication33428074-748a-4751-b2f7-9f24247715fd
relation.isAuthorOfPublication.latestForDiscovery2b4618ae-9c47-4033-94ea-24c9793d73e7
relation.isProjectOfPublicatione14d6486-f3c2-4e1d-90c2-a9739583d9b4
relation.isProjectOfPublication.latestForDiscoverye14d6486-f3c2-4e1d-90c2-a9739583d9b4

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
AbstractSPP2018_ABCD_GENIAL.pdf
Size:
153.07 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.32 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ciTechCare - Comunicações em conferências sem publicação
ESSLei - Comunicações em conferências e congressos internacionais